TAKE : reports strong Q1 FY18 revenue of INR 3543.71 Mn

Chennai, August 14th 2017:TAKE Solutions Ltd. [BSE: 532890 | NSE: TAKE], a globally recognized knowledge and innovation intensive Life Sciences expert, today announced its financial results for Q1 FY18.

The Company, which embarked on a 5-year transformational scale-up journey in the previous year, commenced FY 18 on a tremendously positive note, reporting Q1 revenues of INR 3543.71 Mn, 11.6% growth over the corresponding period in the last year.

In line with the approach defined in its transformational scale-up initiative, TAKE announced the consolidated of its legacy life sciences businesses Navitas, Ecron Acunova and Intelent under the unified go-to-market brand Navitas Life Sciences. This consolidation brings together the legacy Navitas' technology led IP intensive solutions across Clinical, Regulatory and Safety, Ecron Acunova's full-service CRO and Clinical & BA/BE capabilities, as well as Intelent's Big Data Analytics expertise in the form of Navitas Life Sciences - an end-to-end provider of transformative solutions across technology, process and consulting, offering global clients full-service coverage of the Pharma and Biotech R&D market.

Srinivasan H.R., Vice-Chairman and Managing Director, TAKE Solutions said, 'The consolidation of the distinct capabilities and niche expertise of our legacy brands as Navitas Life Sciences has created a tremendously positive business impact, as can be witnessed by the strong Q1 numbers. We are excited to carry forward this momentum through the year as we grow from strength to strength on our mission to emerge as a 5 times larger enterprise by the year 2021.'

About TAKE Solutions

TAKE Solutions is a globally recognized knowledge intensive player, delivering comprehensive and niche solutions in Life Sciences (LS). TAKE offers IP-based software and extensive knowledge-based solutions to enable efficient Clinical, Regulatory, Safety outcomes for global clients. TAKE encompasses specialized capabilities under its Life Sciences business Navitas Life Sciences, whose technology-led Life Sciences services across Clinical, Regulatory and Safety are augmented by full-service CRO with Clinical & BA/BE capabilities and Big Data analytics expertise of its legacy brands Ecron Acunova and Intelent. Navitas Life Sciences delivers flexible and scalable solutions by seamlessly combining best-in-class processes, meaningful and unique industry insight, innovative technology, exacting analytics and a customer-centric culture.

TAKE's significant recognitions include a patent win from the United States Patent and Trademark Office (USPTO) for its 'Method for Optimizing Clinical Data Standardization', a 'Leader' certification in Drug Safety Services & Life Sciences R&D IT Outsourcing from IDC, recognition as the 'Dream Employer of the Year' at the World HRD Congress, the title of 'Most Admired Brand - IT' from the Asian Customer Engagement Forum and a Special Commendation for excellence in Corporate Governance from the Golden Peacock Awards. With its global headquarters in Chennai, India, TAKE has a proven track record of delivering world-class solutions to more than 150 customers worldwide, including 9 of the top 10 global Pharma companies. For more information, please visit www.takesolutions.com.

Contacts::
Samhita Suresh, TAKE Solutions, [phone], [e-mail]
Murugan G, 20:20 MSL, [phone], [e-mail]